About
Noah Davidsohn, Ph.D., is the Chief Scientific Officer and co-founder of Rejuvenate Bio, a San Diego gene-therapy company focused on age-related disease and epigenetic reprogramming. Earlier, he was a research scientist at the Wyss Institute and Harvard Medical School, where the underlying Rejuvenate Bio work originated in George Church's lab. He also serves on the advisory board for the Longevity Biotech 2025 conference.
Areas of interest
longevitygene therapypartial reprogrammingepigenetic rejuvenationsynthetic biologybiotech3D bioprintingreplacement strategyanimal healthtranslational medicine